According to Sumitomo Pharma 's latest financial reports the company's current EPS (TTM) is -$2.44. In 2022 the company made an earnings per share (EPS) of -$0.10 a decrease over its 2021 EPS that were of $0.72.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.44 | 2236.07% |
2022 | -$0.10 | -114.53% |
2021 | $0.72 | -55.44% |
2020 | $1.61 | 32.14% |
2019 | $1.22 | 8% |
2018 | $1.13 | 10.27% |
2017 | $1.02 | 46.03% |
2016 | $0.70 | 70.08% |
2015 | $0.41 | -9.56% |
2014 | $0.46 | 56.71% |
2013 | $0.29 | -38.48% |
2012 | $0.47 | 22.89% |
2011 | $0.38 | -2.84% |
2010 | $0.40 | -38.52% |
2009 | $0.64 |